Brief: Arbutus Reports Second Quarter 2023 Financial Results And Corporate Update
Arbutus Biopharma Corp ABUS.O :
* ARBUTUS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS
AND CORPORATE UPDATE
* ARBUTUS BIOPHARMA CORP - CASH RUNWAY INTO Q1 OF 2025
* ARBUTUS BIOPHARMA CORP - QTRLY LOSS OF $0.10 PER BASIC AND
DILUTED COMMON SHARE
Source text for Eikon: ID:nGNX3sGsLt
Further company coverage: ABUS.O
Recent news on Arbutus Biopharma
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
Arbutus rises after FDA lifts clinical hold for experimental hepatitis B drug
Brief: Arbutus Announces Final Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
Brief: Arbutus Announces Preliminary Results Of Its Us$230 Million Modified “Dutch Auction” Tender Offer
U.S. STOCKS ON THE MOVE-Moderna, O-I Glass, Aveanna Healthcare